3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione CAS NO.827026-45-9
| Lub npe | 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione | ||
| CAS Nr. | 827026-45-9 | ||
| Molecular Formula | C13H11N3O5 | Molecular Luj | 289.24 ib |
| MDL Nr. | TIAB SA 11977267 | EINECS | 1592732-453-0 |
| MP | ≥250 ° C (txog) | BP | 616.6 ± 55.0 ° C (Predicted) |
| Qhov ntom | 1.546 ± 0.06 g / cm3 (Kev kwv yees) | Refractive Index | NA |
| FP | NA | Kev cia khoom | nyob rau hauv inert gas (nitrogen los yog Argon) ntawm 2-8 ° C |
| Qhov tshwm sim | Beige rau Brown khoom | ||
| Purity | 98% | ||
| Daim ntawv thov | lenalidomide intermediates; | ||
| Muaj peev xwm muab khoom | 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione CAS NO.827026-45-9 yog peb cov khoom tsis tu ncua, txawm tias koj xav tau cov qauv me me lossis loj cargo ntawm ntau tshaj tonnage, peb lub tuam txhab tuaj yeem muab nws cov ntaub ntawv | ||
| Yog tias koj txaus siab rau 3-(4-Nitro-1-oxo-1,3-dihydroisoindol-2-yl)piperidine-2,6-dione CAS NO.827026-45-9, xav tias dawb hu rau peb, thiab peb yuav muab koj cov khoom zoo tshaj plaws, tus nqi tsim nyog thiab kev pabcuam zoo tshaj plaws, cia siab tias peb yuav koom tes nrog. | |
| | |
| Xov tooj No. | +86 139 6251 3054 +86 136 2174 3828 |
Cov khoom lag luam tau teev tseg los ntawm lub tuam txhab koom nrog patents, uas tsuas yog rau kev tshawb fawb thiab kev tsim kho thiab tsis yog muag;Cov khoom tswj xyuas yuav raug muag hauv kev ua raws li Suav txoj cai lij choj thiab cov kev cai ntawm lub teb chaws uas lawv yuav, thiab tag nrho cov khoom tsis haum rau tib neeg siv.Yog tias muag, lawv yuav tsim lub teb chaws patent infringement, tag nrho cov kev pheej hmoo raug coj los ntawm tus neeg yuav khoom.
Sau koj cov lus ntawm no thiab xa tuaj rau peb
![N-[3-Chloro-4-(3-fluorobenzyloxy)phenyl]-6-iodoquinazolin-4-amine CAS NO.231278-20-9](http://cdn.globalso.com/shlzpharma/116.png)
![4-[2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoic acid methyl ester CAS NO.155405-80-4](http://cdn.globalso.com/shlzpharma/214.png)
